Literature DB >> 18007417

Unexpected syntheses of seco-cyclopropyltetrahydroquinolines - from a radical 5-exo-trig cyclization reaction: analogs of CC-1065 and the duocarmycins.

Hari Pati1, Tiffany Howard, Heather Townes, Brian Lingerfelt, LuAnne McNulty, Moses Lee.   

Abstract

Analogs of the seco-cyclopyrroloindoline (seco-CPI), the DNA alkylation pharmacophore of CC-1065 and the duocarmycins, can be prepared through a 5-exo-trig radical cyclization of a free radical and a 3-chloro-2-allylic moiety. This manuscript reports an unexpected discovery that, depending on the structure and stability of the free radical, the cyclization process leads to the production of an appreciable amount of seco- cyclopropyltetrahydroquinolines 7a-d along with the seco-cyclopropoyltetra- hydroindoline products (6a-e). For instance, free radical reaction of the bromoallylic chloride 5a produced an equal amount of 6-benzyloxy-N-t-butoxycarbonyl-3- (chloromethyl)furano[e]indoline (6a), and 7-benzyloxy-N-t-butoxycarbonyl-3-chloro- 1,2,3,4-tetrahydrofurano[f]quinoline (7a). Three other examples that produced mixtures of indoline and quinoline products are provided. In only one of the examples reported in this manuscript, the 6-benzyloxy-N-t-butoxycarbonyl-3-(chloromethyl)benzo[e]indoline, was a seco-CBI precursor 6e formed exclusively, consistent with literature precedents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18007417      PMCID: PMC6147511          DOI: 10.3390/90300125

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  17 in total

1.  Synthesis, chemical solvolytic stability and preliminary biological evaluation of (+/-)-N-Boc-CPzI: a pyrazole analog of the left-hand segment of the antitumor agent CC-1065.

Authors:  P G Baraldi; B Cacciari; M J Pineda de las Infantas; R Romagnoli; G Spalluto; P Cozzi; N Mongelli
Journal:  Anticancer Drug Des       Date:  1997-01

2.  Synthesis and preliminary biological evaluations of CC-1065 analogues: effects of different linkers and terminal amides on biological activity.

Authors:  Y Wang; H Yuan; W Ye; S C Wright; H Wang; J W Larrick
Journal:  J Med Chem       Date:  2000-04-20       Impact factor: 7.446

3.  Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells.

Authors:  D A Volpe; J E Tomaszewski; R E Parchment; A Garg; K P Flora; M J Murphy; C K Grieshaber
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.

Authors:  G F Fleming; M J Ratain; S M O'Brien; R L Schilsky; P C Hoffman; J M Richards; N J Vogelzang; D A Kasunic; R H Earhart
Journal:  J Natl Cancer Inst       Date:  1994-03-02       Impact factor: 13.506

5.  Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

Authors:  B J Foster; P M LoRusso; E Poplin; M Zalupski; M Valdivieso; A Wozniak; L Flaherty; D A Kasunic; R H Earhart; L H Baker
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

6.  Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assay.

Authors:  R D Hightower; B U Sevin; J P Perras; M Untch; R Angioli; R Ramos; H Averette
Journal:  Gynecol Oncol       Date:  1992-11       Impact factor: 5.482

7.  Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.

Authors:  L H Li; R C Kelly; M A Warpehoski; J P McGovren; I Gebhard; T F DeKoning
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

8.  Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.

Authors:  L H Li; T F DeKoning; R C Kelly; W C Krueger; J P McGovren; G E Padbury; G L Petzold; T L Wallace; R J Ouding; M D Prairie
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

Review 9.  CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.

Authors:  D L Boger; D S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.

Authors:  D L Boger; W Yun; N Han
Journal:  Bioorg Med Chem       Date:  1995-11       Impact factor: 3.641

View more
  2 in total

1.  Evidence for Dual Site Binding of Nile Blue A toward DNA: Spectroscopic, Thermodynamic, and Molecular Modeling Studies.

Authors:  Mukti Mohammad; Harun Al Rasid Gazi; Kumud Pandav; Prateek Pandya; Md Maidul Islam
Journal:  ACS Omega       Date:  2021-01-16

2.  Cyclization of free radicals at the C-7 position of ethyl indole-2-carboxylate derivatives: an entry to a new class of Duocarmycin Analogues.

Authors:  Naim H Al-Said; Khaled Q Shawakfeh; Wasim N Abdullah
Journal:  Molecules       Date:  2005-12-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.